Enovis Corporation

Financials

Cash from operating activities 301.94 M356.1 M-55.86 M134.99 M113.5 M217.29 M 217.29 M Cash from investing activities -175.08 M-320.48 M-176.39 M-242.47 M-955.47 M179.37 M -153.39 M Cash from financing activities -131.65 M584.91 M-465.13 M127.8 M846.82 M52.4 M 52.4 M Free cash flow 187.15 M251.86 M-155.41 M12.77 M-67.21 M19.92 M 106.05 M

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

ENOV

Financials

Enovis Corporation

Haberler

Needham, Enovis için hedef fiyatı 2027 tahminlerine göre 52 dolara yükseltti

Needham raises Enovis stock price target to $52 on 2027 estimates

Enovis Q4 2025 slides: margin expansion drives earnings beat

Enovis kazancı $0,13 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

Enovis kazançta beklentiyi aştı, gelirde geride kaldı

Enovis beats earnings but misses on revenue

Enovis’in kazanç raporu yaklaşıyor: Agresif satın alma stratejisi toparlanmayı sağlayabilir mi?

Enovis earnings up next: Can aggressive M&A strategy drive turnaround?

Enovis hisseleri zorlu yılda 22,93 dolar ile 52 haftalık dibe vurdu

Enovis stock hits 52-week low at $22.93 amid challenging year

Top 3 Health Care Stocks That Could Blast Off This Month - Enovis (NYSE:ENOV), Hims & Hers Health (NYSE:HIMS)

Small Caps, Chips Lead Stock Market; JPMorgan, Goldman Delta, Taiwan Semiconductor In Focus: Weekly Review